Segall Bryant & Hamill’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-18,349
| Closed | -$579K | – | 545 |
|
|
2016
Q3 | $579K | Buy |
18,349
+78
| +0.4% | +$2.46K | 0.01% | 390 |
|
|
2016
Q2 | $514K | Buy |
18,271
+1,185
| +7% | +$33.3K | 0.01% | 412 |
|
|
2016
Q1 | $621K | Buy |
17,086
+3,950
| +30% | +$144K | 0.02% | 392 |
|
|
2015
Q4 | $526K | Sell |
13,136
-15
| -0.1% | -$601 | 0.01% | 402 |
|
|
2015
Q3 | $375K | Sell |
13,151
-7,121
| -35% | -$203K | 0.01% | 449 |
|
|
2015
Q2 | $668K | Sell |
20,272
-124,386
| -86% | -$4.1M | 0.02% | 386 |
|
|
2015
Q1 | $4.16M | Sell |
144,658
-198,444
| -58% | -$5.71M | 0.09% | 238 |
|
|
2014
Q4 | $9.34M | Buy |
343,102
+43,022
| +14% | +$1.17M | 0.21% | 148 |
|
|
2014
Q3 | $6.4M | Buy |
300,080
+132,244
| +79% | +$2.82M | 0.15% | 178 |
|
|
2014
Q2 | $3.77M | Sell |
167,836
-17,395
| -9% | -$391K | 0.09% | 217 |
|
|
2014
Q1 | $4.68M | Sell |
185,231
-485
| -0.3% | -$12.3K | 0.11% | 205 |
|
|
2013
Q4 | $4.27M | Sell |
185,716
-5,595
| -3% | -$129K | 0.1% | 210 |
|
|
2013
Q3 | $3.64M | Buy |
191,311
+8,236
| +4% | +$157K | 0.09% | 219 |
|
|
2013
Q2 | $2.64M | Buy |
+183,075
| New | +$2.64M | 0.07% | 241 |
|